Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:50 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | PERCEPTIVE ADVISORS LLC | 0 0% | -930,000 (Position Closed) | View |
| 2024-02-14 4:00 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | TANG CAPITAL PARTNERS LP | 0 0% | -1,062,619 (Position Closed) | View |
| 2024-01-26 10:46 am Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | Lepercq De Neuflize Asset Management LLC | 1,026,868 8.4% | 1,026,868 (New Position) | View |
| 2023-10-17 9:05 pm Unchanged | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 0.5% | 0 (Unchanged) | View |
| 2023-10-16 8:56 pm Unchanged | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 0.5% | 0 (Unchanged) | View |
| 2023-06-09 1:03 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | JANUS HENDERSON GROUP PLC JHG | 0 0% | -1,263,065 (Position Closed) | View |
| 2023-06-07 9:44 pm Sale | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,211,262 10.9% | -60,913 (-4.79%) | View |
| 2023-05-26 4:41 pm Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | JANUS HENDERSON GROUP PLC JHG | 1,263,065 12.1% | 726,631 (+135.46%) | View |
| 2023-05-25 11:17 am Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | JANUS HENDERSON GROUP PLC JHG | 536,434 5.1% | 536,434 (New Position) | View |
| 2023-05-22 07:04 am Sale | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,272,175 12.2% | -551,815 (-30.25%) | View |
| 2023-03-17 4:00 pm Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | TANG CAPITAL PARTNERS LP | 1,062,619 9.99% | 1,062,619 (New Position) | View |
| 2023-03-14 10:55 am Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | PERCEPTIVE ADVISORS LLC | 930,000 8.9% | 930,000 (New Position) | View |
| 2022-02-14 10:45 am Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | New Mountain Investments II LLC | 0 0% | -1,009,231 (Position Closed) | View |
| 2021-04-27 9:45 pm Purchase | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,823,990 19.2% | 616,817 (+51.10%) | View |
| 2021-02-12 5:27 pm Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | New Mountain Investments II LLC | 1,009,231 10.63% | 1,009,231 (New Position) | View |
| 2021-01-05 1:52 pm Unchanged | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | SABBY MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
| 2020-05-22 07:38 am Purchase | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Life Science Opportunities Fund VI | 1,207,173 13.1% | 1,207,173 (New Position) | View |
| 2020-05-22 06:46 am Purchase | 13D | BELLEROPHON THERAPEUTICS INC C BLPH | Puissance Cross-Border Opportunities III LLC | 53,327 0.9% | 53,327 (New Position) | View |
| 2020-03-30 10:49 am Purchase | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | SABBY MANAGEMENT LLC | 302,083 11% | 302,083 (New Position) | View |
| 2020-02-14 4:05 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | VENROCK ASSOCIATES IV L P | 3,553,583 4.99% | -2,870,165 (-44.68%) | View |